Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
PETMED EXPRESS INC reported that prior financial statements should not be relied upon.
- Action
- non reliance
- Auditor
- RSM US LLP
Exact text from the filing
” and together with the Q1 2024 Quarterly Report, the 2023 Annual Report and the Historical Quarterly Reports, the “Reports” and all financial statements included in the Reports, collectively the “Affected Financials”), should no longer be relied upon. As a result of the foregoing determined, related press releases, shareholder communications, investor presentations or other communications describing relevant portions of the Affected Financials should no longer be relied upon. The Audit Committee’s conclusion was based on management’s determination that the Company (1) misapplied generally accepted accounting principles relating to certain accruals for sales tax liabilities resulting from sales of the Company’s products and services to its customers and (2) incorrectly valued the deferred tax asset acquired in connection with the Company’s acquisition of PetCareRx in April 2023, in each
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
PETMED EXPRESS INC reported fiscal quarter ended December 31, 2023 results: revenue $65.3 million.
- Period
- fiscal quarter ended December 31, 2023
- Revenue
- $65.3 million
- Result
- preliminary results
Exact text from the filing
Net sales for the quarter ended December 31, 2023, are expected to be $65.3 million
View on SEC.gov